-
-
Cardiovascular companies and cardiovascular topics captured much of the spotlight in healthcare investor conferences that took place last month a little more than a week apart at opposite ends of the country.
-
Researchers from Harvard Medical Schools teaching hospital in Boston decided to test if they could encourage physicians to switch appropriate patients from intravenous (IV) to oral (PO) medications.
-
Abbott Laboratories is not backing down from its decision to increase the price of ritonavir (Norvir) by 500% monthly for patients who take 100 mg a day. Ritonavir is used in almost all protease inhibitor combinations for treating HIV infection.
-
ViaCell will begin to enroll patients in a Phase I/II clinical trial of CB001, a highly purified population of stem cells that has been isolated from umbilical cord blood and multiplied using the companys patented Selective Amplification technology.
-
-
Stokes MJ. Soy and menopausal symptoms. Altern Med Alert 2004;7(5):49-55.
-
Greenfield RH. Stress and multiple sclerosis. Altern Med Alert 2004;7(5):59-60.
-
If an 11-year-old girl comes to your ED with a radius-ulnar fracture, she is X-rayed, casted, and discharged home a minor injury with minor inconveniences.
-
Here are key recommendations from the Atlanta-based Centers for Disease Control and Prevention guidance for preventing and controlling influenza in health care facilities:
